Table of Content

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 MARKET SCOPE
1.2.2 GEOGRAPHIC SCOPE
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY USED FOR THE STUDY
1.4 KEY STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION METHODOLOGY
2.3 MARKET DATA VALIDATION AND TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
FIGURE1: ASEAN AND NORTH ASIA POINT-OF-CARE DIAGNOSTICS MARKET, BY TECHNOLOGY
FIGURE2: ASEAN AND NORTH ASIA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER
4 MARKET OVERVIEW
4.1 ASIA: MARKET DYNAMICS
4.1.1 MAJOR DRIVERS
4.1.2 KEY RESTRAINTS
4.1.3 KEY GROWTH OPPORTUNITIES
4.1.4 INDUSTRY-SPECIFIC CHALLENGES
4.2 ASIA: PRICING TREND ANALYSIS FOR TARGET PRODUCT SEGMENTS (IN TERMS OF USD, AS OF 2020/21)
4.2.1 ASEAN
4.2.2 SOUTH KOREA
4.2.3 GREATER CHINA
4.2.4 OTHER ASIAN COUNTRIES
4.3 ASIA: COVID-SPECIFIC INDUSTRY TRENDS
4.4 ASIA: REGULATORY LANDSCAPE (AS OF 2020/21)

5 POINT OF CARE DIAGNOSTICS MARKET VALUE DATA, BY PRODUCT TYPE (USD MILLION; 2019 ? 2026)*
TABLE 1 ASEAN AND NORTH ASIA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 2 ASEAN AND NORTH ASIA POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
5.1 INFECTIOUS DISEASE DIAGNOSTICS
5.1.1 COVID TESTING
5.1.2 HIV TESTING
5.1.3 RESPIRATORY INFECTION TESTING
5.1.4 INFLUENZA TESTING
5.1.5 TROPICAL DISEASE TESTING
5.1.6 STD TESTING
5.1.7 HEPATITIS C TESTING
5.1.8 HOSPITAL ACQUIRED INFECTION TESTING
5.1.9 OTHER INFECTIOUS DISEASE TESTING
5.2 GLUCOSE MONITORING
5.2.1 GLUCOSE TEST STRIPS
5.2.2 GLUCOMETERS
5.2.3 LANCETS
5.3 CARDIOMETABOLIC MONITORING
5.3.1 CARDIAC MARKER TESTING
5.3.2 HBA1C TESTING
5.3.3 BLOOD GAS AND ELECTROLYTE TESTING
5.4 COAGULATION MONITORING
5.5 PREGNANCY AND FERTILITY TESTING
5.6 URINALYSIS
5.7 CANCER MARKER TESTING
5.8 CHOLESTEROL TESTING
5.9 HEMATOLOGY TESTING
5.10 FECAL OCCULT TESTING
5.11 DRUG OF ABUSE TESTING
5.12 OTHER POC PRODUCTS
6 POINT OF CARE DIAGNOSTICS MARKET VALUE DATA, BY TECHNOLOGY (USD MILLION; 2019 ? 2026)*
TABLE 3 ASEAN AND NORTH ASIA POINT-OF-CARE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
6.1 RAPID TESTS
6.2 IMMUNOASSAY
6.3 LATERAL FLOW ASSAY
6.4 MICROFLUIDICS
6.5 MOLECULAR DIAGNOSTICS
6.6 DIPSTICKS
7 POINT OF CARE DIAGNOSTICS MARKET VALUE DATA, BY END USER (USD MILLION; 2019 ? 2026)*
TABLE 4 ASEAN AND NORTH ASIA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
7.1 HOSPITALS AND CRITICAL CARE CENTERS
7.2 OUTPATIENT AND AMBULATORY CARE CENTERS
7.3 HOME CARE
7.4 OTHER END USERS
8 POINT OF CARE DIAGNOSTICS MARKET VALUE DATA, BY COUNTRY (USD MILLION; 2019 ? 2026)*
8.1 INDONESIA
TABLE 5 INDONESIA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 6 INDONESIA POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 7 INDONESIA POINT-OF-CARE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 8 INDONESIA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
8.2 LAOS AND CAMBODIA
TABLE 9 LAOS AND CAMBODIA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 10 LAOS AND CAMBODIA POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 11 LAOS AND CAMBODIA POINT-OF-CARE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 12 LAOS AND CAMBODIA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
8.3 MALAYSIA
TABLE 13 MALAYSIA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 14 MALAYSIA POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 15 MALAYSIA POINT-OF-CARE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 16 MALAYSIA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
8.4 MYANMAR
TABLE 17 MYANMAR POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 18 MYANMAR POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 19 MYANMAR POINT-OF-CARE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 20 MYANMAR POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
8.5 PHILIPPINES
TABLE 21 PHILIPPINES POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 22 PHILIPPINES POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 23 PHILIPPINES POINT-OF-CARE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 24 PHILIPPINES POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
8.6 SINGAPORE
TABLE 25 SINGAPORE POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 26 SINGAPORE POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 27 SINGAPORE POINT-OF-CARE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 28 SINGAPORE POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
8.7 THAILAND
TABLE 29 THAILAND POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 30 THAILAND POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 31 THAILAND POINT-OF-CARE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 32 THAILAND POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
8.8 VIETNAM
TABLE 33 VIETNAM POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 34 VIETNAM POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 35 VIETNAM POINT-OF-CARE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 36 VIETNAM POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
8.9 SOUTH KOREA
TABLE 37 SOUTH KOREA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 38 SOUTH KOREA POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 39 SOUTH KOREA POINT-OF-CARE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 40 SOUTH KOREA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
8.10 HONG KONG
TABLE 41 HONG KONG KOREA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 42 HONG KONG POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 43 HONG KONG POINT-OF-CARE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 44 HONG KONG POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
8.11 TAIWAN
TABLE 45 TAIWAN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 46 TAIWAN POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 47 TAIWAN POINT-OF-CARE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 48 TAIWAN POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2026 (USD MILLION)
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 ASEAN: POINT OF CARE DIAGNOSTICS MARKET SHARE ANALYSIS BY TOP 5 VENDORS (IN TERMS OF %REVENUE, IN 2020)
9.3 ASEAN: COMPETITIVE SCENARIO (2018-2021)
9.3.1 PRODUCT LAUNCHES
9.3.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
9.3.3 GEOGRAPHIC EXPANSIONS
9.3.4 ACQUISTIONS
9.4 ASEAN: COMPETITIVE LEADERSHIP MAPPING FOR MAJOR PLAYERS (AS OF 2021)
9.4.1 PARTICIPANTS
9.4.2 EMERGING LEADERS
9.4.3 PERVASIVE PLAYERS
9.4.4 STARS
10 COMPANY PROFILES**
(Business overview, product portfolio, industry-specific developments in 2018-2021***)
10.1 ABBOTT LABORATORIES
10.2 ACCUBIOTECH
10.3 BECTON. DICKINSON AND COMPANY
10.4 JOHNSON & JOHNSON
10.5 BIOMERIEUX
10.6 GE HEALTHCARE
10.7 ORTHOCLINICAL DIAGNOSTICS
10.8 BIOTECHNE
10.9 EKF DIAGNOSTICS
10.10 SYSMEX
10.11 ROCHE DIAGNOSTICS
10.12 SEKISUI DIAGNOSTICS
10.13 SIEMENS HEALTHINEERS
10.14 THERMO FISHER SCIENTIFIC
10.15 TRINITY BIOTECH
10.16 CHEMBIO

10. 17 CARDINAL HEALTH

10. 18 PTS DIAGNOSTICS
10.19 QUIDEL
10.20 INSTRUMENTATION LABORATORY (A WERFEN COMPAN
11 APPENDIX